SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-05-003393
Filing Date
2005-12-12
Accepted
2005-12-12 16:34:33
Documents
5
Period of Report
2005-10-31

Document Format Files

Seq Description Document Type Size
1 PEREGRINE PHARMACEUTICALS, INC. peregrine_10-q.htm 10-Q 822082
2 CERTIFICATE OF DESIGNATION peregrine_ex0306.htm EX-3.6 11034
3 CERTIFICATION exh31-1.htm EX-31.1 12532
4 CERTIFICATION exh31-2.htm EX-31.2 12476
5 CERTIFICATION ex-32.htm EX-32 9701
  Complete submission text file 0001019687-05-003393.txt   869425
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 000-17085 | Film No.: 051258633
SIC: 2835 In Vitro & In Vivo Diagnostic Substances